About this Journal Submit a Manuscript Table of Contents
Disease Markers
Volume 2014 (2014), Article ID 386425, 8 pages
http://dx.doi.org/10.1155/2014/386425
Research Article

Avocado Oil Supplementation Modifies Cardiovascular Risk Profile Markers in a Rat Model of Sucrose-Induced Metabolic Changes

1Biochemical and Nutrition Chemistry Area, University of Veracruz, SS Juan Pablo II s/n, 94294 Boca del Río, Ver., Mexico
2Department of Molecular Biology, Faculty of Resource Science and Technology, University Malaysia Sarawak, 94300 Kota Samarahan, Sarawak, Malaysia
3Food Research and Development Unit, Veracruz Institute of Technology, Calz. M.A. de Quevedo 2779, 91860 Veracruz, Ver., Mexico
4Pathology Laboratory, Institute of Forensic Medicine, University of Veracruz, SS Juan Pablo II s/n, 94294 Boca del Río, Ver., Mexico
5Biological-Chemistry Area, Veracruz Institute of Technology, Calz. M.A. de Quevedo 2779, 91860 Veracruz, Ver., Mexico

Received 27 June 2013; Revised 16 December 2013; Accepted 17 December 2013; Published 25 February 2014

Academic Editor: Fabrizia Bamonti

Copyright © 2014 Octavio Carvajal-Zarrabal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The purpose of this study was to evaluate the effects of avocado oil administration on biochemical markers of cardiovascular risk profile in rats with metabolic changes induced by sucrose ingestion. Twenty-five rats were divided into five groups: a control group (CG; basic diet), a sick group (MC; basic diet plus 30% sucrose solution), and three other groups (MCao, MCac, and MCas; basic diet plus 30% sucrose solution plus olive oil and avocado oil extracted by centrifugation or using solvent, resp.). Glucose, total cholesterol, triglycerides, phospholipids, low- and high-density lipoproteins (LDL, HDL), very low-density lipoprotein (VLDL), lactic dehydrogenase, creatine kinase, and high sensitivity C-reactive protein concentration were analyzed. Avocado oil reduces TG, VLDL, and LDL levels, in the LDL case significantly so, without affecting HDL levels. An effect was exhibited by avocado oil similar to olive oil, with no significant difference between avocado oil extracted either by centrifugation or solvent in myocardial injury biochemical indicators. Avocado oil decreased hs-CRP levels, indicating that inflammatory processes were partially reversed. These findings suggested that avocado oil supplementation has a positive health outcome because it reduces inflammatory events and produces positive changes in the biochemical indicators studied, related to the development of metabolic syndrome.

1. Introduction

Food is a factor that plays a key role in life style, a determining influence on health and quality of life. It is known that populations with a high consumption of meat, dairy foods, and sugar have a higher mortality rate than those that feed mainly on fruits, vegetables, fish, and unsaturated oils [1]. Undesirable effects on health are associated with an excessive intake of carbohydrates (sugars) and fats. Manifestations of health disorders in people with metabolic implications are related to the incidence and prevalence of chronic and degenerative diseases such as obesity, diabetes, cardiovascular disease, and dyslipidemia (low HDL-cholesterol and high triglycerides), among others [2, 3]. Although there are many factors that contribute to its development, one of the main causes that lead to these conditions is the diet that is consumed. A diet containing a great amount of nutrients produces a strong impact on structure, physiology, and cellular metabolism. In recent years, the increase in these diseases has become a global public health problem inspite of the increasing medical knowledge for their prevention and treatment; consequently, the nutritional aspect seems to remain vital.

Statistics from the Secretary of Health in Mexico indicate that the incidence of cardiovascular diseases has increased in recent years, so that now they are the leading cause of death worldwide (WHO, 2007). On the other hand, reports found in scientific literature about the health benefits of the Mediterranean diet and olive oil have attracted interest in research on the effects and consumption of oils rich in monounsaturated fatty acids, particularly oleic acid, and its relationship with metabolic syndrome, which predisposes the individual to more serious complications, such as diabetes and cardiovascular diseases [46].

Mexico is a major world producer of avocados; this fruit is a rich potential source of oil (15–30 g/100 g of fruit), mostly monounsaturated [7], and a good source of linoleic acid [8]. It also contains high levels of antioxidants including polyphenols, proanthocyanidins, tocopherols, and carotenoids which have shown positive health outcomes. It has also been established that soluble components of avocado oil confer these antioxidant properties. Studies in human and animal models have shown that this oil helps to control weight, reduces the risk of diabetes [9], normalizes blood cholesterol levels [10], is involved in liver metabolism [11], and helps in skin care [12]. Other studies reported the presence of functional molecules such as glutathione [13], a molecule related to decreased risk of cancer. On the other hand, the unsaponifiable components, rich in antioxidant molecules [14], have also shown beneficial effects on anti-inflammatory processes related to the development of cancer [15].

In the relevant literature, the benefits generated by including olive oil in the diet for cardiovascular disease risk reduction are well documented. Due to similarities in lipid composition between olive oil and avocado oil, it may be assumed that the high concentration of monounsaturated fatty acids in avocado oil could be as adequate as olive oil for lowering blood lipid levels. In addition, the phytochemical components of avocado oil are also related to the disease manifestations associated with an altered metabolic profile; so overall, it is expected that all the beneficial properties of avocado oil will achieve positive health effects.

2. Material and Methods

2.1. Avocado Oil Extraction

There are different technologies for extracting oil from the avocado and they can affect its quality. The oil was obtained from Hass avocado purchased from a local market in the Port of Veracruz, Mexico. When edible maturity had been reached, the avocados were washed and peeled and the seed was removed. Subsequently, the pulp was homogenized by adding tert-butylhydroquinone (TBHQ) at 0.001% (w/w).

2.1.1. Oil Extraction by Centrifugation

The avocado pulp was mixed with water to achieve a 1 : 1 w/v and NaCl (7.5% w/w), the pH was adjusted to 5.5 with ascorbic acid, and the mixture was homogenized in a blender (Black & Decker Model MX 150) at 1,300 rpm for 1 hour at 35°C. Subsequently, the oil was removed by centrifugation at 27000 rpm in a tubular continuous centrifuge (Cepa-Schnell, GLE Model NBS) fed at 2.8 L/min.

2.1.2. Avocado Oil Extraction by Solvent

A homogenate was made with a portion of the avocado pulp and two parts of a mixture of hexane-isopropanol (2 : 3 v/v) in separate funnels, and the oil phase was collected. Subsequently, the solvent was removed in a rotary evaporator (Buchi R-215, Labortechnik AG, Switzerland) at 30°C and 500 mmHg pressure. The remaining solvent was removed by entrainment with nitrogen gas and then the oil was exposed to high vacuum in a freeze dryer for 24 h. Thereafter the oil was stored in refrigeration and protected from light until use.

2.2. Experimental Animals and Diets

In this experiment 25 male Sprague-Dawley weaned rats (6 weeks old and weighing 240 ± 16 g) were purchased from Teklad, Co. (Mexico City), and caged individually in stainless steel boxes in a room with controlled temperature (25°C) and a light-dark cycle of 12 hours. The experimental protocol for the management of experimental animals was approved by the animal ethics committee, Biochemical and Nutrition Chemistry Area, University of Veracruz. The basal diet was prepared according to the American Institute of Nutrition [16] as shown in Table 1. A mixture of corn-canola oil (7.5 g/100 g diet) was used as a source of dietary fat (Patrona from the local market). The experimental diet was prepared based on the composition of the basal diet plus oil (7.5% w/w): olive oil (carbonell), avocado oil extracted by centrifugation or solvent, respectively. Diets were prepared once a week and kept in powder form at 4°C until use. As part of this study, the fatty acid composition of the oils used in preparing diets was analyzed and it was found that all the oils had a rather similar composition, mainly oleic and linoleic acids (Table 2).

tab1
Table 1: Composition of basal and experimental diets formulated according to AIN-76.
tab2
Table 2: Fatty acid composition of dietary oils (%).
2.3. Sucrose-Induced Metabolic Changes Model

The animals were divided into two groups: a control group (CG, ) receiving a basal diet and a group with sucrose-induced metabolic changes (MC, ), which received the basal diet plus 30% sucrose solution as drinking water to induce this condition. The animals had free access to food and water for 16 weeks and food intake was measured daily. At the end of this period, the diet was withdrawn for at least 4 hours and the manifestation of the metabolic characteristics was checked by determining body weight; then serum glucose, triglycerides, and cholesterol levels were determined and obtained by cardiac puncture.

2.4. Animal Treatment
2.4.1. Experimental Diet Management

Once the sucrose-induced metabolic changes model had been obtained, the MC animals were divided into four groups of five rats each. One group was maintained on the basal diet (the sick group, MC); three groups of rats designated, as MCao, MCac, and MCas, respectively, received an experimental diet containing 7.5% w/w oil (olive and avocado extracted by centrifugation or extracted with solvent) as the sole source of dietary fat. These four groups received the experimental diets and water with 30% sucrose solution for 4 weeks. The CG group continued to receive only the diet with corn-canola oil and no sucrose in the drinking water. Diets were prepared once a week and kept refrigerated until use. At the end of the experiment the diet was withdrawn, and the fasting animals were sacrificed through decapitation. Serum glucose, cholesterol, triglyceride, and phospholipid levels were determined. All animals were sacrificed and the organs were extracted for further analysis.

2.5. Biochemical Indicators

All biochemical indicator analyses were carried out on serum blood samples. Glucose was determined with the glucose oxidase method. Total cholesterol (TC), triglycerides (TG), phospholipids (PL), low- and high-density lipoprotein (LDL, HDL), very low-density lipoprotein (VLDL), lactic dehydrogenase (LDH), creatine kinase (CK), and high sensitivity C-reactive protein (hs-CRP) were determined by enzymatic colorimetric methods using commercial kits obtained from Bayer and BioMerieux, using an automated analyzer (RA 1000 XT, Bayer Technicon) and a microplate reader to determine hs-CRP. The fatty acid profile of vegetable oils was determined by gas chromatography (Hewlett Packard 5890, Palo Alto, CA.) using pentadecanoic acid as internal standard. All chemicals used were of analytical grade.

2.6. Statistical Analysis

The data are expressed as the mean ± standard deviation (x ± SD). Statistical significance was determined with analysis of variance procedures, with a post hoc Tukey multiple-range test for comparison of means ( ). Data were analysed using IBMc SPSSc Statistics Version 20, 2011.

3. Results

3.1. Metabolic Characteristics Evaluating Rats in the Control Group and Rats with Sucrose-Induced Metabolic Changes

Table 3 shows growth variables, food and caloric intake, liquid consumption and the biochemical markers assessed in rats of the control group (CG) and those with sucrose-induced metabolic changes (MC).

tab3
Table 3: Growth parameters, food and caloric intake, liquid consumption, and biochemical markers in control (CG) and sucrose-induced metabolic changes (MC) rats.

After 16 weeks, a significant increase ( ) in final body weight and body weight gain was observed in the MC group as compared to the CG group, although the food intake in rats in the CG group was significantly higher ( ) than in the MC group. Contrary to this, the MC group showed a daily liquid intake significantly higher ( ) as compared with the CG group. However, when the daily liquid intake per 100 g in weight was compared between CG and MC groups, this was not significant. The caloric equivalent produced by liquid intake was 10.8 ± 1.7 kcal in the MC group; the CG group did not have any energy intake, because this group received only purified drinking water. Triglyceride levels in the MC group were significantly greater ( ) than in the CG group; however, no significantly different results were found in any group for either glucose or cholesterol levels.

3.2. Effect of Dietary Oils on Metabolic Change Biochemical Indicators

The effect of olive and avocado oils on biochemical indicators in rats with metabolic changes induced by sucrose ingestion after the administration of experimental diets for 4 weeks is shown in Table 4.

tab4
Table 4: Glucose- and lipid-metabolic parameters   ± SD (mg/dL) in rats fed diets with different dietary oil sources during 4 weeks.

MC group triglyceride levels increased significantly ( ), at least 3.7 times with respect to the CG group. On the contrary, MCao, MCac, and MCas groups exhibited reduced levels, although not significant compared to MC and not reaching the lower CG levels. As for phospholipids, the MC group showed significantly increased levels ( ) compared to CG; however, in MCao, MCac, and MCas groups, no significant change was observed when compared to MC, but their results were significantly higher ( ) when compared to CG. LDL levels in MCao and MCac groups did not show significant differences with respect to CG, but there was a very significant increase ( ) in the MC group, much more than the increase ( ) in the MCas group. VLDL in the MC group increased 3.6 times in comparison to CG levels and no significant decrease from there was observed in MCao, MCac, and MCas groups, all still significantly higher ( ) than CG. Significantly different results were not found for any group in the cases of glucose, cholesterol, or high-density lipoproteins (HDL).

3.3. Effect of Dietary Oils on Myocardial Injury Indicators

The effect of dietary olive and avocado oils on myocardial injury indicators in rats with metabolic changes induced by sucrose ingestion is shown in Table 5.

tab5
Table 5: Profile of myocardial injury enzymes in rats fed diets with different dietary oil sources during 4 weeks.

A highly significant increase ( ) of hs-CRP serum levels was observed in the MC group, almost double CG values. The MCao group managed to revert the change in these levels somewhat ( ), while MCac and MCas groups completely returned to CG values. Lactic dehydrogenase (LDH) and creatine kinase (CK) levels did not show any significant differences for any study group compared to CG; however, in MCao, MCac, and MCas groups, CK levels did fall below CG values.

4. Discussion

Metabolic changes are associated with a number of diseases, including obesity, diabetes, hypertension, dyslipidemia, and other abnormalities of importance related to their development. These are grouped into different profiles, such as liver, pancreatic, and cardiovascular functions.

Within this framework, in the present study, significant differences were found for MC groups as compared to the CG group in final body weight and weight gain, which were significantly higher (6 and 11%, resp.), although food intake was significantly lower (54%). These results are consistent with those reported in other studies where metabolic changes were induced by the administration of a sucrose-rich diet in addition to an experimental diet causing changes in the biochemical indicators measured [17, 18]. In relation to serum biochemical indicators associated with the development of metabolic abnormality, it was found that glucose and cholesterol concentrations in MC group rats were similar to those in the CG group and not significant. Reaven and Chang [19] have suggested that this is due to hyperinsulinemia developed in metabolic abnormalities which maintains normal levels of blood glucose. TG levels were significantly higher (56%) in MC group rats (a 2.3 fold increase). Other studies have found similar results [20, 21]; Piatti et al. [22] reported the association in healthy patients between sudden TG elevation and insulin resistance and suggested that the increase in blood TG in vivo inhibits glucose utilization and oxidation stimulated by insulin action in the peripheral tissues. One way to explain blood TG elevation might be to consider a possible increase in the reesterification of fatty acids from the liver as a result of fructose metabolism, as reported by Bezerra et al. [20]; this monosaccharide stems from sucrose hydrolysis and in the liver, fatty acids are mainly used for the HDL and TG synthesis, which in turn raise serum levels.

Few studies have evaluated the influence of avocado oil as a dietary fat on the lipid profile and lipoprotein metabolism, specifically in animal models with manifestations of metabolic disorders. This study found that the dietary intake of olive oil and avocado oil extracted by centrifugation or solvent exerted little or no effect on glucose, cholesterol, and HDL levels, there being no significant changes in the circulating levels of these indicators for any study group.

Among the most important effects observed in this experiment is the significant elevation of TG levels in the MC group, at least 3.8-fold compared with the CG group, a phenomenon reversed with the subsequent administration of olive oil or avocado extracted by centrifugation or solvent. This effect is attributed to the ingestion of a high amount of sucrose in the drinking water and is a feature of the metabolic disorder [23], since several studies demonstrate that high carbohydrate intake is associated with increased TG levels [24]. On the other hand, the MCao, MCac, and MCas groups were able to reduce TG levels significantly (20, 20, and 27%, resp.) compared to the MC group, although without reaching the lower levels of the CG group. These data are consistent with previous findings by Lerman-Garber et al. [9], Carranza et al. [25], and López Ledesma et al. [26], who showed that a diet supplemented with avocado oil for 30 days in diabetic subjects with induced dyslipidemia decreased TG levels by 20, 41.3, and 28.9%, respectively. In addition, the observations reported in this study add support to those postulated by Póveda et al. [27], which indicate that oils rich in monounsaturated fatty acids and micronutrients may help lower TG levels and reduce the unfavorable response in the lipid profile observed with saturated fatty acids. Phospholipids maintained a similar percentage increase (4, 2, and 0%) in the MCao, MCas, and MCac groups, with respect to the SG group, and showed no significant effect on this indicator; however, their levels were all significantly higher, by 33, 30, and 28%, respectively, in relation to the CG group. Other researchers have reported that, although olive oil has a hypocholesterolemic effect on the serum lipid profile [28], there is some evidence to suggest that it does not significantly affect the profile of heart or erythrocyte phospholipids [29]. On the other hand, it has been found that avocado oil supplementation in rats increases the phospholipid fraction in HDL as a surface component [30]; the present study shows that avocado oil, while being a crude oil high in micronutrients, also has a significant percentage of monounsaturated fatty acids (18:1N9 oleic: 54–59%), which could explain its effect to increase phospholipid levels.

It has been established that the consumption of olive oil reduces cholesterol bound to LDL (LDL-C) when replacing a source of saturated fat or one high in carbohydrates [9, 31]. This effect has been demonstrated with oils rich in monounsaturated fatty acids; however, it is not exclusive to olive oil and is also produced by other oils rich in oleic acid, such as avocado oil. This study confirmed that olive oil very significantly decreased (28%) LDL levels in the MCao group and that avocado oil extracted by centrifugation (MCac) or solvent (MCas) reduced very significantly and significantly these levels, by 26 and 23%, respectively, compared with MC group levels.

It is well known that among the relevant mechanisms of atherosclerosis pathogenesis are the oxidation of low-density lipoproteins (LDL) in the artery walls, the proliferation of smooth muscle cells, endothelial activation, and leucocyte fixation.

Among the studies linked to these mechanisms and to the presence of oleic acid are those which relate the type of fatty acid present in the oils consumed to LDL susceptibility to oxidation. Parthasarathy et al. [32] demonstrated that LDL particles rich in oleic acid are markedly more resistant to oxidative changes. This has been corroborated by Abbey et al. [33] and Reaven et al. [34] where this same particle type presented greater resistance to ex vitro oxidation than those rich in linoleic acid. Moreover, Mata et al. [35] reported that supplementation with monounsaturated fatty acids produces a reduction in the synthesis of smooth muscle cells in cell cultivations incubated with human serum. Studies with endothelial cells showed that oleic acid inhibits endothelial activation analysed through VCAM-1 expression (vascular cell adhesion molecule-1) [36]. Carluccio et al. [37] suggested that oleic acid contributes to atherosclerosis prevention by replacing the saturated fatty acids of cell membrane phospholipids and by modulating the genetic expression of molecules implicated in monocyte capture.

Based on all the above, it is possible to link the oleic acid present in both olive and avocado oils used in this study to the variety of mechanisms mentioned.

On the other hand, it is possible that part of the hypocholesterolemic effect observed is due to changes in the metabolism of LDL lipoproteins caused by the ingestion of avocado oil in the diet, an effect related on the one hand to the type of fat and, on the other, to the concentration of biologically active microcomponents acting additively or synergistically and not simply as isolated components [38]. Experimental data indicate that polyphenols from virgin and extra virgin oils might additionally influence lipid metabolism, thus reducing HMG-CoA reductase activity and modifying lipid values [39].

The intake of olive oil (MCao) and avocado oil extracted by centrifugation (MCac) or solvent (MCas) significantly decreased (17, 19, and 22%, resp.) the VLDL levels when compared to the SG group. On the other hand, supplementing a diet with avocado oil not only lowers LDL but also TG associated with VLDL. As it appears, in comparison with olive oil, the crude avocado oil components may be the cause of this metabolic effect in the liver, reducing triglyceride-rich lipoproteins biosynthesis. These observations have been confirmed in previous studies [40, 41].

Metabolic changes did not affect LDH levels; although the levels of this enzyme decreased (9.8%) in the MC group, their values were not significantly different compared to those in the CG group. In the olive oil group (MCao), LDH levels were reduced by 14% (3446 versus 2974 U/L), whereas in the avocado oil groups extracted by centrifugation (MCac) or solvent (MCas), LDH levels decreased by 77% and increased by 4%, respectively, compared with the MC group. Moreover, in all groups, the olive oil (MCao) and avocado oil extracted by centrifugation (MCac) or solvent (MCas) groups, LDH levels decreased by 22, 79, and 6.5%, respectively, in comparison with CG group, but no significant effect was observed because the values of this indicator overlapped with those in the CG group (2974, 802, and 3573 versus 3820 U/L, resp.).

Regarding CK, it was observed that the metabolic abnormality did not significantly affect its levels. The SG group had decreased CK levels (32%) as compared to the CG group; the olive oil group (MCao) exhibited decreased enzyme levels well below those in the CG and MC groups (55 and 35%, resp.) and a decrease of 46 and 55%, respectively, when compared to MCac and MCas data. It should be noted that although both olive oil and avocado oil groups had decreased CK levels, no significant effect was observed when compared with MC and CG groups.

Serum levels of hs-CRP in the MC group showed a very significant increase (1.76 times) compared to the CG group. This is consistent with other studies in humans, since it has been reported that hs-CRP levels are increased in subjects with signs of health disorders from metabolic abnormality [42]; this increase may also heighten the risk of cardiovascular disease [43]. Nevertheless, the olive oil group (MCao) reversed hs-CRP levels, almost reaching CG group levels (1.8 versus 1.7 U/L) but still with a 5.5% significant difference. Meanwhile, avocado oil extracted by centrifugation (MCac) or solvent (MCas) groups reduced hs-CRP levels even more than olive oil so as to attain levels statistically similar to the CG group (1.5 and 1.5 versus 1.7 mg/dL, resp.). As can be observed, both olive oil and avocado oil extracted by centrifugation or solvent reversed the metabolic changes induced by sucrose ingestion significantly and very significantly reducing hs-CRP levels by 40% in the MCao group and by 50% in the MCac and MCas groups, respectively, as compared with the MC group. It has been shown that oils rich in monounsaturated fatty acids do not increase hs-CRP levels [44]; instead, these are lowered in subjects who consume a Mediterranean diet, where the main source of monounsaturated fatty acids is olive oil [45]. Other studies show that elevated hs-CRP levels are directly related to infectious processes, inflammatory response, steatosis, cardiovascular disease, prevalence, and risk of arteriosclerotic ventricular thrombosis [42, 4648]; this is why the use of hs-CRP has been proposed in prognostic stratification in subjects having health disorders with metabolic abnormalities [49].

The inflammatory response and its relationship with atherosclerosis-cardiovascular risk is well demonstrated; however, it is still under discussion if the measurement of increased levels of hs-CRP consistently and significantly predict cardiovascular risk from a clinical point of view [50]. In the present case, one possible explanation of a decrease in hs-CRP (an inflammation biomarker) in a diet with olive or avocado oil (obtained by any method) could be related to cytokine inhibition observed in diets with a high oleic acid content [51], considering that interleukin 6 sets off hepatocyte hs-CRP synthesis [52].

To the best of our knowledge, these markers have not been evaluated in rat models where metabolic changes induced by sucrose ingestion are associated with liver damage caused by abnormalities in liver function. A concentration of normally metabolized molecules occurs which can have a detrimental effect on health, hence the importance of these findings in the study of the effect of dietary oils such as from avocados.

In conclusion, the results suggest that avocado oil and its antioxidant content place it as a potential oil to be used as one of the preventive factors of metabolic syndrome since it reduces TG, LDL, and VLDL levels, significantly so in the case of LDL, without affecting HDL levels. Furthermore the results indicate that avocado oil exerts effects similar to olive oil, and that the type of extraction exerts an effect on only one of the biochemical indicators analyzed. It has also been found that avocado oil extracted by centrifugation or solvent decreases hs-CRP levels, indicating that inflammatory processes have been at least partially reversed, probably because the manifestation time of metabolic change was very short. Further studies are needed to elucidate the effects on cardiovascular risk profile and inflammatory markers and establish the optimal time of avocado oil supplementation in rats with sucrose-induced metabolic changes, as well as the 18:1N9 specific action on human phospholipid fraction biosynthesis in HDL as a surface component.

Conflict of Interests

The authors certify that they do not have any conflict of interests regarding the publication of this paper.

References

  1. S. Gorinstein, S. Poovarodom, H. Leontowicz et al., “Antioxidant properties and bioactive constituents of some rare exotic Thai fruits and comparison with conventional fruits. In vitro and in vivo studies,” Food Research International, vol. 44, no. 7, pp. 2222–2232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Björntorp, “Heart and soul: stress and the metabolic syndrome,” Scandinavian Cardiovascular Journal, vol. 35, no. 3, pp. 172–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. G. L. Vega, “Obesity, the metabolic syndrome, and cardiovascular disease,” American Heart Journal, vol. 142, no. 6, pp. 1108–1116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. M. W. Steven and G. J. Bruce, “Unsaturated fatty acids,” in Food Lipids. Chemistry, Nutrition and Biotechnology, C. C. Akoh and D. B. Min, Eds., pp. 513–538, Marcel Dekker, New York, NY, USA, 2008.
  5. L. W. Cho, “Metabolic syndrome,” Singapore Medical Journal, vol. 52, no. 11, pp. 779–785, 2011. View at Scopus
  6. A. Ghosh, “The metabolic syndrome: a definition dilemma,” Cardiovascular Journal of Africa, vol. 22, no. 6, pp. 295–296, 2011. View at Scopus
  7. R. B. H. Willis, J. S. K. Lim, and H. Greenfield, “Composition of Australian foods: tropical and subtropical fruit,” Food Technology in Australia, vol. 38, pp. 118–123, 1986.
  8. B. Bergh, “Nutritious value of Avocado,” in Proceedings of the Biennial Conference of the Australian Avocado Growers' Federation. California Avocado Society Book, vol. 76, pp. 123–135, Department of Botany and Plant Science, University California, Riverside, Calif, USA, 1992.
  9. I. Lerman-Garber, S. Ichazo-Cerro, J. Zamora-González, et al., “Effect of a high-monounsaturated fat diet enriched with Avocado in NIDDM patients,” Diabetes Care, vol. 17, no. 4, pp. 311–315, 1994. View at Scopus
  10. D. Kritchevsky, S. A. Tepper, S. Wright, et al., “Cholesterol vehicle in experimental atherosclerosis 24: Avocado oil,” Journal of the American College of Nutrition, vol. 22, no. 1, pp. 52–55, 2003. View at Scopus
  11. H. Kawagishi, Y. Fukumoto, M. Hatakeyama et al., “Liver injury suppressing compounds from Avocado (Persea americana),” Journal of Agricultural and Food Chemistry, vol. 49, no. 5, pp. 2215–2221, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. I. E. Danhof, “Potential reversal of chronological and photo-aging of the skin by topical application of natural substances,” Phytotherapy Research, vol. 7, pp. S53–S56, 1993. View at Scopus
  13. K. C. Duester, “Avocados,” Nutrition Today, vol. 35, pp. 151–159, 2000.
  14. Y. F. Lozano, C. D. Mayer, C. Bannon, et al., “Unsaponifiable matter, total sterol and tocopherol contents of Avocado oil varieties,” Journal of the American Oil Chemists' Society, vol. 70, no. 6, pp. 561–565, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Cohen, A. R. Kristal, and J. L. Stanford, “Fruit and vegetable intakes and prostate cancer risk,” Journal of the National Cancer Institute, vol. 92, no. 1, pp. 61–68, 2000. View at Scopus
  16. P. G. Reeves, F. H. Nielsen, and G. C. Fahey Jr., “AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet,” Journal of Nutrition, vol. 123, no. 11, pp. 1939–1951, 1993. View at Scopus
  17. R. M. Oliart Ros, M. E. Torres-Márquez, A. Badillo, et al., “Dietary fatty acids effects on sucrose-induced cardiovascular syndrome in rats,” Journal of Nutritional Biochemistry, vol. 12, no. 4, pp. 207–212, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Hafidi, R. Valdez, and G. Baños, “Possible relationship between altered fatty acid composition of serum, platelets, and aorta and hypertension induced by sugar feeding in rats,” Clinical and Experimental Hypertension, vol. 22, no. 1, pp. 99–108, 2000. View at Scopus
  19. G. M. Reaven and H. Chang, “Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertensive and Wistar-Kyoto rats,” American Journal of Hypertension, vol. 4, no. 1 I, pp. 34–38, 1991. View at Scopus
  20. R. M. N. Bezerra, M. Ueno, M. S. Silva, et al., “A high fructose diet affects the early steps of insulin action in muscle and liver of rats,” Journal of Nutrition, vol. 130, no. 6, pp. 1531–1535, 2000. View at Scopus
  21. A. W. Thorburn, L. H. Storlien, A. B. Jenkins, et al., “Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats,” American Journal of Clinical Nutrition, vol. 49, no. 6, pp. 1155–1163, 1989. View at Scopus
  22. P. M. Piatti, L. D. Monti, L. Baruffaldi et al., “Effects of an acute increase in plasma triglyceride levels on glucose metabolism in man,” Metabolism, vol. 44, no. 7, pp. 883–889, 1995. View at Scopus
  23. M. El Hafidi, A. Cuéllar, J. Ramírez, et al., “Effect of sucrose addition to drinking water, that induces hypertension in the rats, on liver microsomal Δ9 and Δ5-desaturase activities,” Journal of Nutritional Biochemistry, vol. 12, no. 7, pp. 396–403, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. E. J. Parks and M. K. Hellerstein, “Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms,” American Journal of Clinical Nutrition, vol. 71, no. 2, pp. 412–433, 2000. View at Scopus
  25. J. Carranza, M. Alvizouri, M. R. Álvaro, et al., “Efectos del aguacate sobre los niveles de lípidos séricos en pacientes con dislipidemias fenotipo II y IV,” Archivos del Instituto de Cardiología de México, vol. 65, pp. 342–348, 1995.
  26. R. López Ledesma, A. C. Frati Munari, B. C. Hernández Domínguez et al., “Monounsaturated fatty acid (Avocado) rich diet for mild hypercholesterolemia,” Archives of Medical Research, vol. 27, no. 4, pp. 519–523, 1996. View at Scopus
  27. E. Póveda, P. Ayala, R. Milena, et al., “Effects of vegetal oils supplementation on the lipid profile on Wistar rats,” Biomedica, vol. 25, no. 1, pp. 101–109, 2005.
  28. D. Bester, A. J. Esterhuyse, E. J. Truter, et al., “Cardiovascular effects of edible oils: a comparison between four popular edible oils,” Nutrition Research Reviews, vol. 23, no. 2, pp. 334–348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Heyden, “Polyunsaturated and monounsaturated fatty acid the diet to prevent coronary heart disease via cholesterol reduction,” Annals of Nutrition and Metabolism, vol. 38, no. 3, pp. 117–122, 1994. View at Scopus
  30. O. Pérez-Méndez and L. Gracia-Hernández, “El tamaño y la composición de las lipoproteínas de alta densidad (HDL) se modifica en la rata por una dieta suplementada con aguacate “ Hass” (Persea americana Miller),” Archivos de Cardiología de México, vol. 77, no. 1, pp. 17–24, 2007.
  31. L. B. Dixon and N. D. Ernst, “Choose a diet that is low in saturated fat and cholesterol and moderate in total fat: subtle changes to a familiar message,” Journal of Nutrition, vol. 131, no. 2, pp. 510S–526S, 2001. View at Scopus
  32. S. Parthasarathy, J. C. Khoo, E. Miller, et al., “Low density lipoprotein rich in oleic acid is protected agaiinst oxidative modification: implications for dietary prevention of atherosclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 10, pp. 3894–3898, 1990. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Abbey, G. B. Belling, M. Noakes, et al., “Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation,” American Journal of Clinical Nutrition, vol. 57, no. 3, pp. 391–398, 1993. View at Scopus
  34. P. Reaven, S. Parthasarathy, B. J. Grasse, et al., “Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects,” Journal of Clinical Investigation, vol. 91, no. 2, pp. 668–676, 1993. View at Scopus
  35. P. Mata, O. Varela, R. Alonso, et al., “Monounsaturated and polyunsaturated n-6 fatty acid-enriched diets modify LDL oxidation and decrease human coronary smooth muscle cell DNA synthesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 10, pp. 2088–2095, 1997. View at Scopus
  36. C. Carrillo, M. Ma. del Cavia, and S. Alonso-Torre, “Role of oleic acid in immune system,mechanism of action, a review,” Nutrición Hospitalaria, vol. 27, no. 4, pp. 978–990, 2012.
  37. M. A. Carluccio, M. Massaro, C. Bonfrate, et al., “Oleic acid inhibits endothelial activation: a direct vascular antiatherogenic mechanism of a nutritional component in the Mediterranean diet,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 2, pp. 220–228, 1999. View at Scopus
  38. A. P. Simopoulos, “The Mediterranean diets: what is so special about the diet of Greece? The scientific evidence,” Journal of Nutrition, vol. 131, no. 11, pp. 3065S–3073S, 2001. View at Scopus
  39. F. Benkhalti, J. Prost, E. Paz, et al., “Effects of feeding virgin olive oil or their polyphenols on lipid of rat liver,” Nutrition Research, vol. 22, no. 9, pp. 1067–1075, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. H. E. Anderson, S. Vázquez Cabrera, R. Lozano, et al., “Efecto del consumo de aguacate (Persea americana Mill) sobre el perfil lipídico en adultos con dislipidemia,” Anales Venezolanos de Nutrición, vol. 22, no. 2, pp. 84–89, 2009.
  41. P. Pérez-Martínez, J. López-Miranda, J. Delgado-Lista, et al., “Aceite de oliva y prevención cardiovascular: más que una grasa,” Clínica e Investigación en Arteriosclerosis, vol. 18, no. 5, pp. 195–205, 2006.
  42. M. K. Rutter, J. B. Meigs, L. M. Sullivan, et al., “C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study,” Circulation, vol. 110, no. 4, pp. 380–385, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Tomiyama, Y. Koji, M. Yambe et al., “Brachial-ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome,” Circulation Journal, vol. 69, no. 7, pp. 815–822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Desroches, W. R. Archer, M.-E. Paradis et al., “Baseline plasma C-reactive protein concentrations influence lipid and lipoprotein responses to low-fat and high monounsaturated fatty acid diets in healthy men,” Journal of Nutrition, vol. 136, no. 4, pp. 1005–1011, 2006. View at Scopus
  45. K. Esposito, R. Marfella, M. Ciotola et al., “Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial,” Journal of the American Medical Association, vol. 292, no. 12, pp. 1440–1446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Fröhlich, A. Imhof, G. Berg et al., “Association between C-reactive protein and features of the metabolic syndrome,” Diabetes Care, vol. 23, no. 12, pp. 1835–1839, 2000. View at Scopus
  47. D. A. Morrow and P. M. Ridker, “C-reactive protein, inflammation, and coronary risk,” Medical Clinics of North America, vol. 84, no. 1, pp. 149–161, 2000. View at Scopus
  48. M. di Napoli, M. Schwaninger, R. Cappelli et al., “Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP pooling project members,” Stroke, vol. 36, no. 6, pp. 1316–1329, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Lamblin, F. Mouquet, B. Hennache et al., “High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure,” European Heart Journal, vol. 26, no. 21, pp. 2245–2250, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. O. Yousuf, B. D. Mohanty, S. T. Martin, et al., “High-sensitivity C-reactive protein and cardiovascular disease,” Journal of the American College of Cardiology, vol. 62, no. 5, pp. 397–408, 2013.
  51. R. Verlengia, R. Gorjão, C. C. Kanunfre, et al., “Effect of arachidonic acid on proliferation, cytokines production and pleiotropic genes expression in Jurkat cells—a comparison with oleic acid,” Life Sciences, vol. 73, no. 23, pp. 2939–2951, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus